Projects overview

Sort by

Toggle all information

PATROLS | Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment

01-01-2018

-

30-09-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
H2020-EU.2.1.2.2. Ensuring the safe and sustainable development and application of nanotechnologies
H2020-NMBP-2017-two-stage
NMBP-29-2017 Advanced and realistic models and assays for nanomaterial hazard assessment

GRACIOUS | GRACIOUS: Grouping, Read-Across, CharacterIsation and classificatiOn framework for regUlatory risk assessment of manufactured nanomaterials and Safer design of nano-enabled products

01-01-2018

-

30-09-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
H2020-EU.2.1.2.2. Ensuring the safe and sustainable development and application of nanotechnologies
H2020-NMBP-2017-two-stage
NMBP-28-2017 Framework and strategies for nanomaterial characterisation, classification, grouping and read-across for risk analysis

REFINE | Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices

01-12-2017

-

28-02-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies
H2020-EU.2.1.2.2. Ensuring the safe and sustainable development and application of nanotechnologies
H2020-NMBP-2017-two-stage
NMBP-14-2017 Regulatory Science Framework for assessment of risk benefit ratio of Nanomedicines and Biomaterials
Powered by Chris Decubber BV